Brian Cahill - Feb 2, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Stock symbol
EGRX
Transactions as of
Feb 2, 2022
Transactions value $
-$36,249
Form type
4
Date filed
2/4/2022, 03:58 PM
Previous filing
Feb 1, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$36.2K -805 -3.16% $45.03 24.7K Feb 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.